Clinical Edge Journal Scan

Clinical Edge Journal Scan

Specific SNP may predict lenalidomide efficacy after autologous stem cell transplantation in MCL

Publish date: May 18, 2023

• Read More

Clinical Edge Journal Scan

Venetoclax achieves a high undetectable measurable residual disease rate in ibrutinib-treated high-risk CLL

Publish date: May 18, 2023

• Read More

Clinical Edge Journal Scan

Chemotherapy+rituximab causes prolonged hypogammaglobulinemia in children with mature B-NHL

Publish date: May 18, 2023

• Read More

Clinical Edge Journal Scan

Short subcutaneous rituximab maintenance after induction improves outcomes in low-tumor burden FL

Publish date: May 18, 2023

• Read More

Clinical Edge Journal Scan

Front line ibrutinib-based regimens gain ground against CLL

Publish date: May 18, 2023

• Read More

Clinical Edge Journal Scan

First-line venetoclax-obinutuzumab +/− ibrutinib tops chemoimmunotherapy in advanced CLL

Publish date: May 18, 2023

• Read More

Clinical Edge Journal Scan

Commentary: New genetic information and treatments for DLBCL, May 2023

Publish date: May 3, 2023

• Read More

Clinical Edge Journal Scan

Benefits of Pola-R-CHP over other novel agents against newly diagnosed DLBCL

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Addition of bortezomib to R-CHOP improves survival in DLBCL molecular subgroups

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Ibrutinib offers better efficacy and tolerability over idelalisib+rituximab in relapsed/refractory CLL

Publish date: April 17, 2023

• Read More

Pages

• « first
• …
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• last »